Lung Cancer

From Johnson & Johnson discontinuing their talc-based baby powder in the U.S. and Canada after numerous lawsuits that cited the talc, a mineral similar to asbestos, caused cancer, to the ramifications of delayed cancer surgeries being felt by patients, here’s everything happening in the cancer space this week.

Understanding lung cancer.

Here is a list of clinical trials that are currently happening within the mesothelioma space.

New therapies approved following innovative research are increasing survival rates for patients with advanced lung cancer.

How a cancer diagnosis leaves one woman feeling humbled.

From plans to sue the School District of Philadelphia over a mesothelioma diagnosis to Dwayne “The Rock” Johnson singing for a 3-year-old with acute lymphoblastic leukemia, here’s what is making headlines in the cancer space this week.

Disparities in lung cancer care must be closed to improve patient outcomes.

The keynote speaker at the CURE® Patient-Focused Sessions at the Annual New York Lung Cancers Symposium® heeded warning signs and urges others to do the same.

Researchers combine therapies in clinical trials to find the best match for patients with small cell lung cancer.

An aptly named app brings community to patients and caregivers around the world.

From the latest report on the “State of Lung Cancer” to NASA-style workouts for patients with cancer, here’s what is making headlines in the cancer space this week.

Researchers have discovered that a diet rich in fiber and yogurt may protect against lung cancer.

For Lung Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

From a palliative care bill clearing the House to a Washington Redskins player revealing a cancer diagnosis, here’s what is making headlines in the cancer space this week.

The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found.

A seven-year mesothelioma survivor encourages patients with cancer to be their own advocate.

A phase 3 trial compared Keytruda versus chemotherapy for patients with advanced pretreated malignant pleural mesothelioma.

Cediranib combined with platinum-based chemotherapy helped patients live longer than placebo.

After a 10-year battle with cancer, the beloved actress, wife, mother and advocate passed away at 80.

Traveling helped me remove myself from the storyline of cancer and reconnect with the world around me.

Here’s a sneak peek at what’s inside our Summer 2019 issue.

The American Lung Association’s chief medical officer discusses e-cigarette use and answers common questions surrounding this increasing epidemic.

A registered dietician discussed the importance of maintaining one’s weight while going through treatment for mesothelioma.

The earlier lung cancer is detected, the better chance a person has of surviving the disease. Knowing the risk factors and statistics will help you to understand how you can minimize your possibility of developing the disease.

CURE® spoke with one expert about the various treatment options and current clinical trials available to patients with mesothelioma, as well as what they have to look forward to in the future.

Sometimes in life, we are fortunate enough to meet an individual who inspires us, motivating us to be our best. I was fortunate to meet Valerie “Val” Betancourt, M.S.N., RN, NP-C, OCN, over 20 years ago. Little did I know this was going to be the beginning of a wonderful friendship.

From landmark Senate legislation to the Pink Lemonade Stand Challenge, here’s what is making headlines in the cancer space this week.

CURE spoke with one expert about mesothelioma symptoms that patients can be on the lookout for, as well as how to be knowledgeable about certain risk factors.

GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress for her leadership in lung cancer research.

GO2 Foundation will recognize Prof. Peters at the 20th International Lung Cancer Congress for her leadership in lung cancer research.